16 September 2026 editorial review · Item
Genetic risk score (GRS) newborn screening: review notes
These notes document the scope actually reviewed, including source-access limits. They are not independent clinical certification or a guarantee that every claim was verified.
Read the item evidence page →Preventing and curing evidence review — 16 September 2026
- Disposition: reviewed; no confirmed content change. Current item
lastReviewed: 2026-08-27. - Claim check: GRS2 discrimination is population-level; high score is neither disease diagnosis nor deterministic outcome. POInT result reinforces separation of enrichment from prevention efficacy.
- Registry NCT03364868: COMPLETED; updated 2024-10-08; enrollment 1050 (ACTUAL); primary completion 2024-06-28 (ACTUAL); results not posted in retrieved record.
- Primary publication/regulatory sources checked or consulted: dc18-1785; S0140-6736%2825%2901726-X; PMID 26404926; jama.2013.6285; s00125-023-05953-0.